Benzinga | Mar 4, 2021 04:44PM EST

Cellectis Q4 EPS $(0.88) Misses $(0.78) Estimate, Sales $15.63M Beat $7.64M Estimate

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.88) per share which missed the analyst consensus estimate of $(0.78) by 12.82 percent. This is a 20.55 percent decrease over losses of $(0.73) per share from the same period last year. The company reported quarterly sales of $15.63 million which beat the analyst consensus estimate of $7.64 million by 104.61 percent. This is a 146.72 percent increase over sales of $6.34 million the same period last year.